|
|
Article: Albany College of Pharmacy and Health Sciences Receives $1.37 Million Grant to Assist in Development of Anthrax Antidote.
- Article from:
- Bioterrorism Week
- Article date:
- February 2, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
The Pharmaceutical Research Institute (PRI) at Albany College of Pharmacy and Health Sciences will receive a total of $1,367,191 over the next five years as part of a joint effort with researchers at the University of Toronto, Rensselaer Polytechnic Institute and Biophage Pharma Inc. to develop an antidote ('antitoxin') for anthrax. The research grant is being funded by the National Institutes of Health (NIH), with a total of $6.2 million allocated to the four institutions. Work on the project has already been initiated.
Shaker Mousa, Ph.D., executive vice president and chairman of PRI, will lead the team of PRI investigators who will focus their part of the ...